Boston Scientific recently shared new clinical data sets on the use of its Eluvia drug-eluting stent for treating peripheral ...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ...

In this interview, Sir Prof. Cato T. Laurencin, the 2025 Coulter Lecturer, discusses how he is addressing today’s medical ...

Abbott got some really good news today… and that’s been my favorite. But also Boston Scientific. I prefer Boston Scientific to Edwards Lifesciences, really, really, right now.” Overall ...

“The extent of the federal investment in research, including biomedical research ... Harvard’s teaching hospitals in Boston were among the nation’s largest recipients of NIH grants last ...

Has Boston Scientific (BSX) been one of those stocks ... In contrast, Arbutus Biopharma falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 508 stocks and ...

Boston Scientific CFO Dan Brennan is set to retire and will transition out of the role at the end of June, the company said Wednesday. Jon Monson, Boston Scientific’s senior vice president for ...

Jon Monson | Boston Scientific Boston Scientific has promoted Jon Monson to CFO following the retirement of Dan Brennan, who has spent nearly 30 years at the company, including over a decade as CFO.

Boston Scientific Corporation BSX posted better-than-expected earnings for the first quarter on Wednesday. The company reported first-quarter 2025 revenues of $4.66 billion, beating the consensus ...

Fertitta Family College of Medicine curriculum. In addition to the knowledge of the scientific facts, studying integrated biomedical sciences will also help students develop effective reasoning skills ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost of doing business this year, according to the company’s ...